Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: A case report
- 1 November 2014
- journal article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 8 (11) , 1561-1562
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cystic fibrosis and Crohn’s disease: Successful treatment and long term remission with infliximabWorld Journal of Gastroenterology, 2010
- Association of tumour necrosis factor alpha variants with the CF pulmonary phenotypeThorax, 2005
- Pathophysiology and Management of Pulmonary Infections in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Inflammatory Cytokines in Cystic Fibrosis LungsAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Identification of the Cystic Fibrosis Gene: Genetic AnalysisScience, 1989